Diabetes

Survey data reveal rates of diabetes prevalence by subtype among adults.

The first generic drug company in Fayetteville, Arkansas, is opening to provide cost-effective drugs to a community with limited access.

What should these pharmacists do?

Metabolic syndrome involves multiple disease states including hypertension, hyperlipidemia, and possibly diabetes.

A global phase 3a trial successfully demonstrated greater reductions in HbA1c and body weight with a oral semaglutide drug treatment than with dulaglutide, as well as a a comparable number of adverse events in 458 Japanese adults with type 2 diabetes between these medications.

Some researchers propose that vasomotor symptoms may signal physiologic processes that might be associated with other related systemic health diagnoses.

Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.

Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ESC Congress in Munich, Germany.

Higher-than-recommended physical activity levels can help older adults avoid chronic diseases, disability, and cognitive decline for longer.

Amring Pharmaceuticals Inc. is committed to putting people first in all it does, providing high-quality generic medications and excellent customer service at a reasonable cost.

Increase productivity, strengthen camaraderie among colleagues, and motivate an even sharper focus on serving our patients. Sounds like a win-win-win, and it is! Here is how to do it.

The FDA has approved the longest-lasting self-applied continuous glucose monitor (CGM) in the United States market.

The FDA has approved the FreeStyle Libre 14-day Flash Glucose Monitoring system, now the longest-lasting self-applied continuous glucose monitor (CGM) in the US market.

A look at last week's top stories in the world of pharmacy.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

When it comes to diabetes, that lack of a shared language can be a tremendous barrier to care.

Study establishes increased risk of all-site cancer for both men and women with diabetes, but the excess risk of cancer is greater for women.

Growing evidence suggests that integrating clinical pharmacy specialists into medical care teams that focus on diabetes improves glycemic control, and leads to better clinical outcomes in primary care settings.

Study: Vitamin E was related to significant reductions in blood glucose and glycated hemoglobin compared with the placebo.

Patients on atypical antipsychotics have 3 to 5 times greater risk of type 2 diabetes than others.

Rachele Berria, MD, PhD, Vice President and Head of the Diabetes Medical Unit at Sanofi, explains the role of pharmacists in helping patients manage their diabetes.

Ronnie Aronson, MD, FRCPC, FACE, Medical Director of LMC Diabetes and Endocrinology, discusses the key role pharmacists play in treating patients with CGM systems.

New data demonstrate that evolocumab (Repatha) significantly reduced low-density lipoprotein cholesterol and non-high density lipoprotein cholesterol in patients with type 2 diabetes plus hypercholesterolemia or mixed dyslipidemia.

Newly published findings from the PIONEER 1 phase 3a trial show that once-daily once-daily oral semaglutide was associated with significant reductions in blood sugar in adults with type 2 diabetes.